
empower. your. health.
Who we help
Our programs are designed for:
- Individuals who want to lose weight and keep it off for good.
- Individuals who want to lose weight, but like many, couldn’t tolerate weight loss jabs
- Those living with long-term conditions like diabetes, high blood pressure, or metabolic syndrome, who want to reverse or control their disease better.
- Partners and parents who want a healthier future for themselves and their families.
- Health-conscious individuals seeking deeper knowledge. Even if you are currently healthy, our programs offer a valuable insight into preventing long-term diseases.
- Healthcare professionals and coaches looking to expand their knowledge and better support their clients.
Whatever your starting point, we’ll help you build a new direction.


You’re part of a special group of people—people who are seriously motivated to take charge of their wellbeing.
Whether your goal is weight loss, reversing disease, or preventing it—you’re exactly the kind of person we’re here to help.
Our programs are built on proven science, designed to help you to stay well for life. We don’t offer fad diets or quick fixes. We help you to become the best version of you—for good!
Let us share our knowledge with you to empower you to be the best version of you.
Our vision
To change how the world approaches weight loss and health. We believe in giving people the tools to prevent, reverse, and overcome long-term disease. No gimmicks. Just science-backed strategies that work.


What We Offer
We create online video programs focused on:
- Weight-loss
- Disease reversal and prevention
- Cellular health and longevity
Every course is written and delivered by senior doctors. It’s not just what we say—it’s who’s saying it. Our team has spent decades in the field, treating patients and staying at the cutting edge of medicine and metabolic science.
Why choose healthbuddi?
- Expert-led: our programs are developed and taught by doctors.
- Evidence-based: backed by real science.
- Flexible: learn on your terms, any place, any time.
- Supportive: join a like-minded community that’s on the same path.

our mission is simple
To educate people so they can reverse long-term diseases including obesity. We believe in your body’s innate ability to heal itself when you are given the right information and opportunity.

Elevate your health with programs by doctors
our values
We have three fundamental values that guide all our actions and decisions:
Dedicated to improving your health: our clients are at the heart of everything we do, delivering solutions that exceed expectations.
Honesty: transparent, straightforward, and science-led.
Integrity: we hold ourselves to medical and ethical standards in every detail.








Start Your Journey
We’re here to support you—whether you’re starting afresh or picking yourself up again. You may want to lose weight, have given up on weight loss jabs due to side effects, or want to reverse disease. It’s time to take back control.
Ready to feel better, live better, and be better?
Any questions?
Get in touch!

Journal Articles
1. MW Hope-Ross, PB Chell, GN Kervick and PJ McDonnell. Recurrent corneal erosions: Clinical features. Eye 1994,8:373-377.
2. MW Hope-Ross, JM Gibson, PB Chell, P Corridan and EE Kritzinger. Dye enhanced laser photocoagulation in the treatment of peripapillary subretinal neovascular membrane. Acta Ophthalmologica 1994,72:134-137.
3. PB Chell, MW Hope-Ross, P Shah and PJ McDonnell. Long term follow up of a single continuous adjustable suture in penetrating keratoplasty. Eye 1996;10:133-137.
4. PB Chell, MW Hope-Ross, P Shah and PJ McDonnell. Letter. Eye 1997;11:141-2.
5. Chatterjee S, Hope-Ross M, Clark IH, Chell PB. A rare and unusual congenital arteriovenous communication of the retina. Eye (Lond). 2004 Jan;18(1):74-5. PMID: 14707971
6. Singh JK, Dhawahir FE, Hamid AF, Chell PB. The use of dye in ophthalmology. J Audiov Media Med. 2004 Jun;27(2):62-7. PMID: 15223583
7. A Lockwood, PB Chell and M Hope-Ross. Diabetic keratopathy. Eye. 2005,20(7):837-9. PMID: 16215544
8. Rayside M, Spokes D, Barber K, Chell PB. Cataract presenting as manifest refractive astigmatism: case study. Eye (Lond). 2007 Sep;21(9):1239-41. PMID: 17641682
9. M Hope-Ross, DJ Magee, DP O'Donoghue and JJ Murphy. Ulcerative colitis complicated by lymphoma and adenocarcinoma. British Journal of Surgery 1985,72:22.
10. TJ Ryan, HF Given, JJ Murphy, M Hope-Ross and G Byrne. The use of a new occlusive dressing in the management of venous stasis ulceration. Royal Society of Medicine, International Congress and Symposium Series: No.88;99-105.
11. LMT Collum, M Hillery, M McDermott, A Benedict-Smith, M Hope-Ross, P Mullaney, F Kinsella, M Hickey-Dwyer. The management of herpes zoster ophthalmicus. Bull Soc Belge Ophthalmol 1987,224:9-14.
12. M Hope-Ross, S Travers and D Mooney. Solar retinopathy. British Journal of Ophthalmology 1988,72:931-4.
13. M Hope-Ross and D Mooney. Intraocular lens power calculation. Eye 1988,2:367-9.
14. LMT Collum, M Hillery, A Benedict-Smith, F Kinsella, M Hope-Ross, W Power and B Read. Sodium cromoglycate in tear film disease. Progress in Allergy and Clinical Immunology 1989:251-253. Publisher, H. Huber.
15. M Hope-Ross, JA Allen, TAS Buchanan and DB Archer. Autonomic function in Holmes Adie syndrome. Eye 1990,4:607-612.
16. K Coleman, M Hope-Ross, M McCabe, R Coleman, D Mooney. Disc drusen and angioid streaks in pseudoxanthoma elasticum. American Journal of Ophthalmology 1991,112:166-170.
17. W Power, M Hope-Ross and D Mooney. Preoperative pupil fatigue. Journal of Cataract and Refractive Surgery 1992,18:306-309.
18. MW Hope-Ross, G Mahon, T Gardiner and DB Archer. Ultrastructural findings in solar retinopathy. Eye 1993,7:29-33.
19. MW Hope-Ross, G Mahon and PB Johnston. Ocular siderosis. Eye 1993,7:419-425.
20. MW Hope-Ross, PJ McDonnell, G Naylor, P Corridan and A Tan-Yee. The management of post keratoplasty astigmatism by postoperative adjustment of a single continuous suture. Eye 1993,7:625-692.
21. MW Hope-Ross, LA Yannuzzi, E Gragoudas, CA Puliafito, DR Guyer, JA Slakter, J Sorenson, S Krupsky, DA Orlock. Adverse reactions to indocyanine green. Ophthalmology 1994,101:529-533.
22. LA Yannuzzi, MW Hope-Ross, JA Slakter, DR Guyer, J Sorenson, A Ho, B Freund, DA Orlock. Analysis of vascularised pigment epithelial detachments using indocyanine green videoangiography. Retina 1994,14:99-113.
23. MW Hope-Ross, PB Chell, GN Kervick and PJ McDonnell. Recurrent corneal erosions: Clinical features. Eye 1994,8:373-377.
24. MW Hope-Ross, PB Chell, GN Kervick, PJ McDonnell and H Jones. Oral tetracycline in the management of recurrent corneal erosions. Eye 1994,8:384-388.
25. Guyer DR, LA Yannuzzi, JA Slakter, JA Sorenson, M Hope-Ross and DA Orlock. Digital indocyanine green videoangiography of occult choroidal neovascularisation. Ophthalmology 1994,101:1727-1737.
26. Y Stavrou, PI Murray and M Hope-Ross. Detection of Varicella-Zoster Virus DNA in patients with uveitis but no cutaneous eruption. Eye 1994,8:684-687.
27. PB Chell, MW Hope-Ross, P Shah and PJ McDonnell. Long term follow up of a single continuous adjustable suture in penetrating keratoplasty. Eye 1996;10:133-137.
28. PB Chell, MW Hope-Ross, P Shah and PJ McDonnell. Letter. Eye 1997;11:141-2.
29. JF Kirwan, T Potamitis, S EL-Kasaby, MW Hope-Ross and GA Sutton. Microbial keratitis in intensive care. British Medical Journal 1997:314:433-4.
30. Peck-Lin Lip, F Belgore, AD Blann, MW Hope-Ross, JM Gibson, GY Lip. Plasma vascular endothelial growth factor and soluble VEGF receptor FLT-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Investigative Ophthalmology and Visual Science, 2000;41:2115-2119.
31. Peck-Lin Lip and MW Hope-Ross. Idiopathic Polypoidal Choroidal Vasculopathy: a disease with diverse clinical spectrum and systemic associations. Eye 2000:14:695-700.
32. Peck-Lin Lip, AD Blann, MW Hope-Ross, JM Gibson and GY Lip. Age-related macular degeneration is associated with haemorheological abnormalities and endothelial dysfunction. Ophthalmology. 2001:108:705-710.
33. Peck-Lin Lip, AD Blann, MW Hope-Ross, JM Gibson and GY Lip. Plasma vascular endothelial growth factor, angiopoietin-2 and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol 2004;88:1543-1546.
34. Tailor R, Elaraoud I, Good P, Hope-Ross M, Scott RA. A case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment: a review of the literature on the use of hydroxychloroquine in renal impairment. Ophthalmol Med. 2012;2012:182747.
35. Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev. 2009 Aug;5(3):151-6.
Case Reports
1. M Hope-Ross, P Mullaney, P Condon, LMT Collum. Ocular cicatricial pemphigoid and oesophageal carcinoma. Acta Ophthalmologica 1990,68:361-3.
2. M Hope-Ross and SS Johnston. The morning glory syndrome associated with sphenoethmoidal encephalocele. Ophthalmic Paediatrics and Genetics 1990,2:147-153.
3. Thurairajan G, Hope-Ross MW, Situnayake RD and Murray PI. Polyarthropathy, Orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. British Journal Of Rheumatology 1997,36:120-123.
4. PL Lip, L Mowatt-Dixon and M Hope-Ross. Central serous retinopathy complicated by massive subretinal haemorrhage. British Journal of Ophthalmology 1999:83:990-991.
5. A Kulkarni, M Hope-Ross, D Beale and Green. Glaucoma mimicked by carotid ophthalmic artery aneurysm: a rare cause of insidious visual loss. Eye 2000:14:405-406.
6. S Al-Husainy and M Hope-Ross. Alkali injury complicated by Choroidal Neovascularisation. Eye 2000:14:904-905.
7. S Chatterjee, Clarke I, PB Chell and M Hope-Ross. A rare and unusual congenital arteriovenous communication of the retina. Eye 2004:18:74-75.
8. Unusual ocular presentation of systemic non-Hodgkin's Lymphoma. Ocular Immunology and Inflammation. Revision submitted August 2006.
Letters
1. AM O’Driscoll, P Shah, R Aggarwal, PB Chell, MW Hope-Ross and PJ McDonnell. Ophthalmic sequelae of alkali injury. British Medical Journal 1995,310:943.
2. PB Chell, MW Hope-Ross, P Shah and PJ McDonnell. Letter. Eye 1997;11:141-2.
3. PL Lip, L Mowatt-Dixon and M Hope-Ross. Letter. British Journal of Ophthalmology 2000:84:936-937.
Review Articles
1. MW Hope-Ross and PL Lip. Indocyanine Green Angiography. Continuing Medical Education Journal. 1998:2:81-85.
2. M Hope-Ross and PB Chell. Refractive Aspects of Cataract Surgery. Lead article in Eye News. 1999:6:15-19.
3. M Hope-Ross. Cystoid Macular Oedema - a persistent problem. Lead article in Eye News. 2001:8:7-12.
4. M Hope-Ross. Diabetes and Cataract Surgery. Refractive Eye News. 2002:1(1):18.
5. M Hope-Ross. Multifocal intraocular lenses. Lead article in Refractive Eye News. 2002:1(2):11-18.
6. M Hope-Ross. Double trouble. Refractive Eye News. 2002:4.
7. S Chatterjee, S Chattopadhya, M Hope-Ross and PL Lip. Hypertension and the Eye: changing perspectives. Journal of Human Hypertension. 2002:16:667-675.
8. M Hope-Ross. Phakodynamics I. Refractive Eye News. 2003.
9. M Hope-Ross. Phakodynamics II. Refractive Eye News. 2003.
10. M Hope-Ross. Top Ten Tips: Managing Vitreous Loss. Refractive Eye News. 2004.
11. Age-related macular degeneration. Birmingham Medical Institute publication, January 2005.
Books
1. Key Topics in Ophthalmology. Editors: R Taylor, P Shah, and PI Murray. Consultant Editor: AR Fielder. Chapter: Cataract and Endophthalmitis. Bios Medical Publishing, 1995. Second edition, 2002.
2. Indocyanine Green Angiography: Imaging of the Choroid. Editors: LA Yannuzzi, J Slakter, H Flower. Chapter 4: The Indocyanine Green Molecule. Mosby, 1996.
3. The Diet Whisperer: The Secrets of Permanent Weight Loss. Amazon, 2020.
4. The Diet Whisperer: 12 Week Reset Plan. PB Chell and M Hope-Ross. Yellow Kite, 2022.
5. The Diet Whisperer Weight Loss Journal. M Hope-Ross and PB Chell. Amazon, 2022.